Dual inhibitors of histone deacetylases and other cancer-related targets: A pharmacological perspective
Yuan GaoSchool of Clinical Medicine, Guangdong Pharmaceutical University, Guangzhou, Guangdong 510000, PR ChinaHang ZhangKey Laboratory of Elemene Class Anti-Cancer Chinese Medicine of Zhejiang Province, PR China; Engineering Laboratory of Development and Application of Traditional Chinese Medicine from Zhejiang Province, PR China; Collaborative Innovation Center of Chinese Medicines from Zhejiang Province, PR China; College of Pharmacy, School of Medicine, Hangzhou Normal University, Hangzhou, Zhejiang 311121, PR China; School of Clinical Medicine, Guangdong Pharmaceutical University, Guangzhou, Guangdong 510000, PR China; Department of Basic Medicine, School of Medicine, Hangzhou Normal University, Hangzhou, Zhejiang 311121, PR ChinaFrédéric LirussiUniversité de Bourgogne-Franche Comté, I-SITE, FranceCarmen GarridoUniversité de Bourgogne-Franche Comté, I-SITE, FranceXiang‐Yang YeKey Laboratory of Elemene Class Anti-Cancer Chinese Medicine of Zhejiang Province, PR China; Engineering Laboratory of Development and Application of Traditional Chinese Medicine from Zhejiang Province, PR China; Collaborative Innovation Center of Chinese Medicines from Zhejiang Province, PR China; College of Pharmacy, School of Medicine, Hangzhou Normal University, Hangzhou, Zhejiang 311121, PR China. Electronic address: [email protected]Tian XieKey Laboratory of Elemene Class Anti-Cancer Chinese Medicine of Zhejiang Province, PR China; Engineering Laboratory of Development and Application of Traditional Chinese Medicine from Zhejiang Province, PR China; Collaborative Innovation Center of Chinese Medicines from Zhejiang Province, PR China; College of Pharmacy, School of Medicine, Hangzhou Normal University, Hangzhou, Zhejiang 311121, PR China. Electronic address: [email protected]
2020en
Ochiq kirishBronza
ABI
Annotatsiya
Annotatsiya mavjud emas.
Identifikatorlar
Iqtiboslar va manbalar
2 ta iqtibos0 ta foydalanilgan manba